Oppenheimer analyst Suraj Kalia reiterated a Perform rating on Procept BioRobotics Corp (NASDAQ: PRCT).The analyst comments "The Aquablation procedure vs ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments